UBS Group »

Oncternal Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Oncternal Therapeutics shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Oncternal Therapeutics

Apr 2024May 2024Jun 2024Jul 2024Aug 2024Sep 2024Oct 202480010001200140016005001000
Value ($)Share countHistorical Oncternal Therapeutics position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Oncternal Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncternal Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.6k 1.2k 1.32
2024-06-30 $760 100 7.60
2024-03-31 $900 100 9.00